Stony brook university hospital launches covid-19 surveillance testing program powered by applied dna's assay kit and services

Stony brook, n.y.--(business wire)---- $apdn #covid19--applied dna sciences, inc., (nasdaq: apdn) (“applied dna” or the "company") a leader in polymerase chain reaction (pcr)-based dna manufacturing, today announced that its linea™ covid-19 assay kit (the “assay kit”) has been selected by stony brook university hospital (sbuh) for use in sbuh's newly launched covid-19 surveillance testing program (the “program”). at peak operations, the program will utilize frequent pooled testing to enable the early detection an
APDN Ratings Summary
APDN Quant Ranking